Investigating the cardiovascular benefits of wild rice consumption
Official title: A Multidisciplinary Investigation of Cardiovascular Benefits of Wild Rice
Run by University of Manitoba · NCT04119791 · Data updated 2026-11-12
This study is testing whether eating wild rice every day for a month can improve heart health in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 40 Years |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | University of Manitoba Academic / other |
| Locations | 1 site (Winnipeg, Manitoba) |
| Status | Recruiting |
| Started | November 5, 2024 |
| Main results expected | January 30, 2026 |
| Study ends | January 30, 2028 |
| Registry record updated | March 3, 2025 |
| Trial ID | NCT04119791 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy adults aged 20 to 40 years, both male and female.
✕Probably not a fit
Patients who are pregnant, lactating, smokers, obese, or on medications for cardiovascular, diabetes, or cancer diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves 24 healthy adult males and females who will consume approximately 30 grams of wild rice daily for 28 days. The primary aim is to assess the impact of wild rice on cardiovascular risk factors before and after the intervention. The study is designed as a pilot to explore the potential health benefits of wild rice, which has not been previously tested in clinical trials. The research is conducted by the Department of Food and Human Nutritional Sciences at the University of Manitoba, known for its contributions to food and nutrition research.
Why it matters
Potential benefit: If successful, this study could provide insights into dietary interventions that may reduce cardiovascular risk factors.
How similar studies have gone: While the effects of wild rice have not been tested in clinical trials, other studies on functional foods have shown promising results in improving health outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male * Female * Both genders are healthy * 20 - 40 years old Exclusion Criteria: * Non-pregnant * Non-lactating * Non-smokers * Not obese (Body Mass Index (BMI) \< 30) * Not currently on any medications for cardiovascular, diabetes, and cancer diseases
Where it's running
-
St. Boniface Hospital Research Center Asper clinical
Winnipeg, Manitoba, Canada Recruiting
Study contacts
- Principal investigator: Mohammed H Moghadasian, PhD — University of Manitoba
- Study coordinator: Mohammed H Moghadasian, PhD
- Email: mmoghadasian@sbrc.ca
- Phone: 204-235-3934
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Study on how carotenoids in diet affect young children's health
This study looks at how eating colorful fruits and vegetables affects the health and vision of young children by checking the levels of carotenoids in their blood and skin.
-
Wellness program for promoting healthy aging
This study is testing a wellness program that includes exercise, diet, and mental health support to see if it helps older adults stay healthy and active as they age.
-
Assessing Urolithin A Levels in Home-Collected Blood Samples
This study is testing how well people can collect their own blood samples at home to see if a supplement or pomegranate juice can help measure levels of Urolithin A, which might be important for healthy aging.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.